Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Antimicrobial Resistance

Antiseptic Resistance: What Do We Know and What Does It Mean?

Albert T Sheldon
American Society for Clinical Laboratory Science July 2005, 18 (3) 181-187; DOI: https://doi.org/10.29074/ascls.18.3.181
Albert T Sheldon Jr
is President, Antibiotics and Antiseptic Consultants Inc, Silver Spring MD
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ATSheldon@Starpower.net
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Albert T Sheldon Jr, PhD⇑
    1. is President, Antibiotics and Antiseptic Consultants Inc, Silver Spring MD
  1. Address for correspondence: Albert T Sheldon Jr PhD, President, Antibiotic and Antiseptic Consultants Inc, (AAC), 8206 Queen Annes Drive, Silver Spring MD 20910. (301) 920-1902. ATSheldon{at}Starpower.net
  1. Identify the mechanism of action and targets of antiseptics.

  2. Discuss the mechanisms of resistance to antiseptics.

  3. Describe the intrinsic and acquired mechanisms of antiseptic nonsusceptibility.

  4. Discuss the mechanisms used to disseminate resistant determinants of antiseptics.

Extract

Biocides (antiseptics, disinfectants, preservatives, sterilants) are used in clinical medicine as intervention strategies that prevent the dissemination of nosocomial pathogens. Biocides are also used for personal hygiene and to prevent cross-contamination of food-borne pathogens in homes, restaurants, day care centers, and nursing homes. However, laboratory evidence has emerged suggesting that the mechanism of nonsusceptibility to biocides may counter-select for resistance to antibiotics. Nature conserves successful survival strategies. Using existing mechanisms of resistance to antibiotics and their means of dissemination, microorganisms have adopted this same survival strategy for biocide nonsusceptibility. These mechanisms are intrinsic in nature or are acquired. The consequences to biocide efficacy in the clinical setting are probably not significant from the biocide perspective. But, the selective pressure biocides exert on bacterial populations that have mechanisms of resistance similar to those to antibiotics or that are also substrates for antibiotic resistance is of concern.

Semmelweis's mandate that physicians wash examining fingers with chlorine to prevent puerperal (childbed) fever provided the scientific evidence to justify the use of biocides in the practice of medicine.1 Biocides (antiseptics, disinfectants, preservatives, and sterilants) are now an integral component in the practice of clinical medicine and serve primarily to prevent the dissemination of nosocomial pathogens in the hospital environment.2 Antiseptics are used as surgical hand scrubs, healthcare personnel hand washes, preoperative skin preparations, and total body washes. Biocides are also used in vascular catheter-care site preparation and are impregnated into catheters to prevent catheter related blood stream infections.3-5 Disinfectants are used to decontaminate or…

ABBREVIATIONS: CM = cytoplasmic membrane; LPS = lipopolysaccharides; MRSA = methicillin-resistant Staphylococcus aureus; OM = outer membrane; PG = peptidoglycan; PMF = proton motive force; RND = resistance-nodulation-division.

    INDEX TERMS
  • biocide
  • biofilm
  • efflux
  • mechanism of action
  1. Identify the mechanism of action and targets of antiseptics.

  2. Discuss the mechanisms of resistance to antiseptics.

  3. Describe the intrinsic and acquired mechanisms of antiseptic nonsusceptibility.

  4. Discuss the mechanisms used to disseminate resistant determinants of antiseptics.

  • © Copyright 2005 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 18 (3)
American Society for Clinical Laboratory Science
Vol. 18, Issue 3
Summer 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antiseptic Resistance: What Do We Know and What Does It Mean?
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antiseptic Resistance: What Do We Know and What Does It Mean?
Albert T Sheldon
American Society for Clinical Laboratory Science Jul 2005, 18 (3) 181-187; DOI: 10.29074/ascls.18.3.181

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Antiseptic Resistance: What Do We Know and What Does It Mean?
Albert T Sheldon
American Society for Clinical Laboratory Science Jul 2005, 18 (3) 181-187; DOI: 10.29074/ascls.18.3.181
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antibiotic Resistance: A Survival Strategy
  • Topical Antiseptics in Healthcare
Show more Focus: Antimicrobial Resistance

Similar Articles

Keywords

  • biocide
  • biofilm
  • efflux
  • mechanism of action

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire